Cancer Research UK partners with VC firm in $25m deal

Charity Cancer Research UK has united with SV Health Investors, a venture capital and growth equity firm, to develop new cancer medicines for patients.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

Cancer Research UK forms immunotherapy alliance

28 March 2019 Cancer Research UK has formed a multimillion-pound drug discovery alliance with fellow charity LifeArc and Japanese company Ono Pharmaceutical.

Big Pharma

Cancer Research UK invests £14m in biotherapeutics hub

19 September 2018 Researchers from three London universities and the Francis Crick Institute have joined together to form a hub for cancer biotherapeutics research and treatment, made possible by a £14 million investment from charity Cancer Research UK.

More on this story

Biotechnology

Cancer Research UK forms immunotherapy alliance

28 March 2019 Cancer Research UK has formed a multimillion-pound drug discovery alliance with fellow charity LifeArc and Japanese company Ono Pharmaceutical.

Big Pharma

Cancer Research UK invests £14m in biotherapeutics hub

More on this story

Biotechnology

Cancer Research UK forms immunotherapy alliance

28 March 2019 Cancer Research UK has formed a multimillion-pound drug discovery alliance with fellow charity LifeArc and Japanese company Ono Pharmaceutical.

Big Pharma

Cancer Research UK invests £14m in biotherapeutics hub